SEARCH

SEARCH BY CITATION

References

  • Aoi N., Nakayama T., Soma M. et al. 2010. Association of the insulin-like growth factor1 gene with myocardial infarction in Japanese subjects. – Hereditas 147: 215224.
  • Chu Z. M., Croft K. D., Kingsbury D. A. et al. 2000. Cytochrome P450 metabolites of arachidonic acid may be important mediators in angiotensin II-induced vasoconstriction in the rat mesentery in vivo. – Clin. Sci. (Lond) 98: 277282.
  • Cornelis M. C., El-Sohemy A. and Campos H. 2004. Genetic polymorphism of CYP1A2 increases the risk of myocardial infarction. – J. Med. Genet. 41: 758762.
  • Elbekai R. H. and El-Kadi A. O. 2006. Cytochrome P450 enzymes: central players in cardiovascular health and disease. – Pharmacol. Ther. 112: 564587.
  • Fava C., Montagnana M., Almgren P. et al. 2008. The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure. – Hypertension 52: 373380.
  • Fleming I. 2001. Cytochrome P450 and vascular homeostasis. – Circ. Res. 89: 753762.
  • Frazier L., Johnson R. L., Sparks E. 2005. Genomics and cardiovascular disease. – J. Nurs. Scholarsh. 37: 315321.
  • Funk M., Endler G., Freitag R. et al. 2004. CYP2C9*2 and CYP2C9*3 alleles confer a lower risk for myocardial infarction. – Clin. Chem. 50: 23952398.
  • Gainer J. V., Bellamine A., Dawson E. P. et al. 2005. Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. – Circulation 111: 6369.
  • Gross G. J., Falck J. R., Gross E. R. et al. 2005. Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited. – Cardiovasc. Res. 68: 1825.
  • Hengstenberg C., Holmer S.R., Mayer B. et al. 2000. Evaluation of the aldosterone synthase (CYP11B2) gene polymorphism in patients with myocardial infarction. – Hypertension 35: 704709.
  • Hill E., Fitzpatrick F. and Murphy R. C. 1992. Biological activity and metabolism of 20-hydroxyeicosatetraenoic acid in the human platelet. – Br. J. Pharmacol. 106: 267274.
  • Imig J. D., Pham B. T., LeBlanc E. A. et al. 2000. Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses. – Hypertension 35: 307312.
  • Laffer C. L., Gainer J. V., Waterman M. R. et al. 2008. The T8590C polymorphism of CYP4A11 and 20-hydroxyeicosatetraenoic acid in essential hypertension. – Hypertension 51: 767772.
  • Letonja M., Peterlin B., Bregar D. et al. 2005. Are the T/C polymorphism of the CYP17 gene and the tetranucleotide repeat (TTTA) polymorphism of the CYP19 gene genetic markers for premature coronary artery disease in Caucasians?Folia Biol. (Praha) 51: 7681.
  • Mayer B., Lieb W., Götz A. et al. 2005. Association of the T8590C polymorphism of CYP4A11 with hypertension in the MONICA Augsburg echocardiographic substudy. – Hypertension 46: 766771.
  • McGiff J. C. and Quilley J. 2001. 20-Hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure. – Curr. Opin. Nephrol. Hypertens. 10: 231237.
  • Morris R. W. and Kaplan N. L. 2002. On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. – Genet. Epidemiol. 23: 221233.
  • Naganuma T., Nakayama T., Sato N. et al. 2008. Association of extracellular superoxide dismutase gene with cerebral infarction in women: a haplotype-based case-control study. – Hereditas 145: 283292.
  • Nakayama T., Soma M., Saito S. et al. 2002. Association of a novel single nucleotide polymorphism of the prostacyclin synthase gene with myocardial infarction. – Am. Heart J. 143: 797801.
  • Nakayama T., Asai S., Sato N. et al. 2007. PDE4D gene in the STRK1 region on 5q12: susceptibility gene for ischemic stroke. – Curr. Med. Chem. 14: 31713178.
  • Nithipatikom K., Gross E. R., Endsley M. P. et al. 2004. Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway. – Circ. Res. 95: e6571.
  • Nordlie M. A., Wold L. E. and Kloner R. A. 2005. Genetic contributors toward increased risk for ischemic heart disease. – J. Mol. Cell. Cardiol. 39: 667679.
  • Quigley R., Baum M., Reddy K. M. et al. 2000. Effects of 20-HETE and 19(S)-HETE on rabbit proximal straight tubule volume transport. – Am. J. Physiol. Renal. Physiol. 278: 949953.
  • Roman R. J. 2002. P-450 metabolites of arachidonic acid in the control of cardiovascular function. – Physiol. Rev. 82: 131185.
  • Schwartzman M. L., Abraham N. G., Masferrer J. et al. 1985. Cytochrome P450 dependent metabolism of arachidonic acid in bovine corneal epithelium. – Biochem. Biophys. Res. Commun. 132: 343351.
  • Spiecker M., Darius H., Hankeln T. et al. 2004. Risk of coro nary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2. – Circulation 110: 21322136.
  • Sugimoto K., Akasaka H., Katsuya T. et al. 2008. A polymorphism regulates CYP4A11 transcriptional activity and is associated with hypertension in a Japanese population. – Hypertension 52: 11421148.
  • Vazquez B., Rios A. and Escalante B. 1995. Arachidonic acid metabolism modulates vasopressin-induced renal vasoconstriction. – Life Sci. 56: 14551466.
  • Wang X. L., Greco M., Sim A. S. et al. 2002. Effect of CYP1A1 MspI polymorphism on cigarette smoking related coronary artery disease and diabetes. – Atherosclerosis 162: 391397.
  • Ward N. C., Tsai I. J., Barden A. et al. 2008. A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure. – Hypertension 51: 13931398.
  • Williams J. S., Hopkins P. N., Jeunemaitre X. et al. 2011. CYP4A11 T8590C polymorphism, salt-sensitive hyperten sion, and renal blood flow. – J. Hypertens. 29: 19131918.
  • Winkelmann B. R. and Hager J. 2000. Genetic variation in coro nary heart disease and myocardial infarction: methodological overview and clinical evidence. – Pharmacogenomics 1: 7394.
  • Yamaguchi M., Nakayama T., Fu Z. et al. 2010. The haplotype of the CACNA1B gene associated with cerebral infarction in Japanese. – Hereditas 147: 313319.
  • Yasar U., Bennet A. M., Eliasson E. et al. 2003. Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction. – Pharmacogenetics 13: 715720.